Placebo for Rimegepant 75 mg, VYDURA 75 mg oral lyophilisate
C4951012/BHV3000-407
Approved small_molecule active
Quick answer
Placebo for Rimegepant 75 mg, VYDURA 75 mg oral lyophilisate for migraine headaches with or without aura is a Approved program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- migraine headaches with or without aura
- Phase
- Approved
- Modality
- small_molecule
- Status
- active